Vancouver, British Columbia–(Newsfile Corp. – June 16, 2026) – The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the “Company” or “BPC”), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the previously announced episode of The Human Upgrade with Dave Asprey featuring Justin Kirkland, Chief Scientific Officer of the Company, is now available. The episode is live on Apple Podcasts, Spotify, YouTube, and at daveasprey.com.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
The Precision Peptide Company (CSE: BPC) has exciting news! Their Chief Scientific Officer, Justin Kirkland, is featured in the latest episode of The Human Upgrade with Dave Asprey, now available for streaming.
- Innovation in Wellness: Learn about cutting-edge peptide formulations.
- Available Now: Stream the episode on Apple Podcasts, Spotify, and YouTube.
- Expert Insights: Gain knowledge from a leading figure in peptide science.
- Public Company: BPC trades on the CSE under the ticker BPC and OTCQB under PNGAF.
Why it matters: This episode highlights the advancements in wellness technology and positions BPC as a key player in the industry.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.